mTOR Pathway Substrates Present High Activation in Vascular Malformations and Significantly Decrease with Age

Area of Science:

• Vascular biology and cell signaling.
• Dermatology and medical research.

Background:

• Vascular anomalies cause significant patient morbidity and are challenging to treat.
• The mammalian target of rapamycin (mTOR) pathway is implicated in vascular malformation development.
• Specific mechanisms of mTOR dysregulation in these conditions remain unclear.

Purpose of the Study:

• To investigate the activation status of key mammalian target of rapamycin (mTOR) pathway substrates.
• To assess the role of mTOR signaling in the pathogenesis of vascular anomalies.

Main Methods:

• Histopathological analysis of tissue samples from 82 patients with various vascular malformations and healthy controls.
• Immunohistochemical staining for p70 S6 Kinase, 4EBP1, and p-4EBP1.
• Statistical analysis using R packages (FactoMineR, factoextra).

Main Results:

• Vascular malformations exhibited significantly higher mTOR substrate activation compared to healthy tissues.
• Elevated p-4EBP1 expression was noted in females with malformations.
• mTOR substrate expression decreased with increasing age.

Conclusions:

• Increased mTOR substrate expression in vascular malformations supports its role in abnormal vascular development.
• Age-dependent changes in mTOR signaling indicate potential for age-specific therapeutic strategies.
• Understanding mTOR pathway activation offers a potential therapeutic target for personalized medicine approaches.